As a UN service, WHO vaccine prequalification must be entirely commercially impartial and not play any role in commercial decision-making. Rather, it is dedicated to maintaining rigorous efficacy, quality and safety standards of vaccines to be procured by UN agencies. However, since manufacturers will seek to understand and review the potential market when considering submission of a vaccine for prequalification, information is provided here that may assist them in this task.
Features of the vaccines market
The vaccines market incorporates a number of manufacturers located in both high-income countries, and in low- and middle-income countries (LMICs). These manufacturers supply an increasingly diverse array of vaccine products. While sales to high-income countries generate the largest revenues from vaccines, sales to LMICs represent the largest volume of vaccines sold.
Compared to the pharmaceutical market, the vaccine market is relatively small and concentrated on both supply and demand sides. It is highly regulated and largely dependent on public purchasers and donor policies. It has some very distinct features which mean assessing and understanding vaccine pricing and procurement is a complex task. For example, the vaccines market is made up of individual markets for individual vaccines or vaccine types, each with its own specificities, particularly on the supply side